Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ginseng Stem Cell Biotechnology is a specialized biotechnology company focused on the research, development, and commercialization of plant stem cell technologies, specifically derived from wild ginseng. The company utilizes a proprietary platform to isolate and cultivate cambium-derived stem cells, which are known for their high potency and stability compared to traditional plant extracts. Their products are primarily used in the health supplement and cosmeceutical industries, targeting anti-aging, immune support, and metabolic health. By leveraging advanced bioprocessing techniques, the company aims to provide standardized, high-quality bioactive compounds for global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ginseng Stem Cell Biotechnology.